Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-064085
Filing Date
2011-11-14
Accepted
2011-11-14 14:34:54
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v239957_10q.htm 10-Q 1012169
2 EXHIBIT 31.1 v239957_ex31-1.htm EX-31.1 15374
3 EXHIBIT 32.1 v239957_ex32-1.htm EX-32.1 5573
  Complete submission text file 0001144204-11-064085.txt   3083183

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ck0001420030-20110930.xsd EX-101.SCH 12647
5 XBRL INSTANCE DOCUMENT ck0001420030-20110930.xml EX-101.INS 375583
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001420030-20110930_cal.xml EX-101.CAL 40716
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001420030-20110930_def.xml EX-101.DEF 96498
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001420030-20110930_lab.xml EX-101.LAB 103574
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001420030-20110930_pre.xml EX-101.PRE 104921
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-Q | Act: 34 | File No.: 000-53071 | Film No.: 111201114
SIC: 6770 Blank Checks